Integral Diagnostics (ASX:IDX) — Material Events
ASX:IDX · 6 articles in the last 12 months · 100% assessed
Click a band to jump to that tier
Major ≥90
Significant 75–89
Notable 50–74
Routine <50
Not assessed
Integral Diagnostics flags softer Q1 as labour shortages pressure FY27 marginsHigh
IDX flags softer Q1 and guides FY27 revenue growth at 4%-6%
29 Oct 2026
·Annual General Meeting Presentation
·Unexpected
·88
Integral Diagnostics Reports 25% Revenue Growth and Appoints New CFO Jenny MartinMedium
Integral Diagnostics reports strong FY26 preliminary results and appoints new CFO Jenny Martin
10 Aug 2026
·Preliminary Financial Results and Executive Appointment
·85
Integral Diagnostics Surges with 55.6% Revenue Growth and Raises DividendMedium
Integral Diagnostics posts strong half-year growth with 55.6% revenue increase and declares 3.3c dividend
24 Feb 2026
·Appendix 4D Preliminary Final Report
·85
Integral Diagnostics Welcomes Jason Martinez as CEO to Lead Next Growth PhaseMedium
Integral Diagnostics appoints Jason Martinez as new CEO, succeeding retiring Ian Kadish
6 Aug 2026
·Executive Appointment
·60
Integral Diagnostics Names Jason Martinez as CEO Starting August 2026Medium
Integral Diagnostics appoints Jason Martinez as MD & CEO effective 6 August 2026
25 Mar 2026
·Executive Appointment
·50
No articles in this tier for the last 12 months.
Market Mentions
7
- appeared in market wrap coverage
These are market wrap articles where Integral Diagnostics (ASX:IDX) was mentioned. They reflect broader market coverage, not company-specific announcements.
Healthcare Wrap - Week 44 (26 Oct -> 30 Oct) 2026
31 Oct 2026
Market Wrap - Week 35 (24 Aug -> 28 Aug) 2026
29 Aug 2026
Healthcare Wrap - Week 35 (24 Aug -> 28 Aug) 2026
29 Aug 2026
Healthcare Wrap - Week 33 (10 Aug -> 14 Aug) 2026
15 Aug 2026
Healthcare Wrap - Week 32 (3 Aug -> 7 Aug) 2026
8 Aug 2026